In the current review article, we will focus on the modulation of the p62-Keap1- NRF2-ARE pathway for selective targeting of autophagy, oxidative stress, and mitochondrial dysfunction in prion diseases as therapeutic intervention strategy. This evidence concerns the gene NFE2L2 and prion disease.